Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierChimie et Biologie des Membranes et des Nanoobjets [CBMN]
dc.contributor.authorABARKAN, Myriam
dc.contributor.authorFOIS, Giulia R.
dc.contributor.authorVOUILLAC-MENDOZA, Caroline
dc.contributor.authorAHMED, Serge H.
dc.contributor.authorGUILLEM, Karine
dc.date.accessioned2024-10-04T12:49:35Z
dc.date.available2024-10-04T12:49:35Z
dc.date.issued2022-08-30
dc.identifier.issn1740-634Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/202262
dc.description.abstractEnNicotine addiction develops after prolonged drug use and escalation of drug intake. However, because of difficulties in demonstrating escalation of nicotine use in rats, its underlying neuroadaptations still remain poorly understood. Here we report that access to unusually high doses of nicotine (i.e., from 30 µg to 240 µg/kg/injection) for self-administration precipitated a rapid and robust escalation of nicotine intake and increased the motivation for the drug in rats. This nicotine intake escalation also induced long-lasting changes in vmPFC neuronal activity both before and during nicotine self-administration. Specifically, after escalation of nicotine intake, basal vmPFC neuronal activity increased above pre-escalation and control activity levels, while ongoing nicotine self-administration restored these neuronal changes. Finally, simulation of the restoring effects of nicotine with in vivo optogenetic inhibition of vmPFC neurons caused a selective de-escalation of nicotine self-administration.
dc.description.sponsorshipDysfonctions attentionnelles d'origine préfrontale dans l'addiction à la nicotine - ANR-15-CE37-0008en_US
dc.language.isoENen_US
dc.subject.enNicotine escalation
dc.subject.enAddiction
dc.subject.enPrefrontal cortex
dc.subject.enIn vivo neuronal activity
dc.subject.enOptogenetic
dc.title.enAltered neuronal activity in the ventromedial prefrontal cortex drives nicotine intake escalation
dc.title.alternativeNeuropsychopharmacol.en_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1038/s41386-022-01428-9en_US
dc.subject.halChimie/Matériauxen_US
dc.identifier.pubmed36042320en_US
bordeaux.journalNeuropsychopharmacologyen_US
bordeaux.page1-10en_US
bordeaux.hal.laboratoriesCBMN : Chimie & de Biologie des Membranes & des Nano-objets - UMR 5248en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionBordeaux INPen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Neuropsychopharmacology&rft.date=2022-08-30&rft.spage=1-10&rft.epage=1-10&rft.eissn=1740-634X&rft.issn=1740-634X&rft.au=ABARKAN,%20Myriam&FOIS,%20Giulia%20R.&VOUILLAC-MENDOZA,%20Caroline&AHMED,%20Serge%20H.&GUILLEM,%20Karine&rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée